Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prognostic factors for adult patients with hemorrhagic moyamoya disease in the acute stage.

Yu Z, Zheng J, Liu X, Wen D, Guo R, Li M, You C, Li H, Ma L, Yang M.

Clin Neurol Neurosurg. 2019 Sep;184:105409. doi: 10.1016/j.clineuro.2019.105409. Epub 2019 Jul 2.

PMID:
31302379
2.

Patterns of acute intracranial hemorrhage in adult patients with bilateral and unilateral moyamoya disease.

Yu Z, Zheng J, Guo R, Li H, You C, Ma L.

Curr Neurovasc Res. 2019 Jun 20. doi: 10.2174/1567202616666190621093652. [Epub ahead of print]

PMID:
31223087
3.

Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Li Q, Qu L, Yuan Y, Xu B, Guo Y, Xu K, Yu J.

Biomed Rep. 2018 Feb;8(2):191-197. doi: 10.3892/br.2017.1030. Epub 2017 Dec 15.

4.

Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.

Wang QN, Bao XY, Zhang Y, Zhang Q, Li DS, Duan L.

J Neurosurg. 2018 Jun 1:1-8. doi: 10.3171/2017.12.JNS172246. [Epub ahead of print]

PMID:
29999465
5.

Difference in Angiographic Characteristics Between Hemorrhagic And Nonhemorrhagic Hemispheres Associated with Hemorrhage Risk of Moyamoya Disease in Adults: A Self-Controlled Study.

Liu P, Liu AH, Han C, Chen C, Lv XL, Li DS, Ge HJ, Jin HW, Li YX, Duan L.

World Neurosurg. 2016 Nov;95:348-356. doi: 10.1016/j.wneu.2016.08.033. Epub 2016 Aug 21.

PMID:
27554309
6.

Comparison of Acute Moyamoya Disease-Related and Idiopathic Primary Intraventricular Hemorrhage in Adult Patients.

Yu Z, Guo R, Zheng J, Li M, Wen D, Li H, You C, Ma L.

World Neurosurg. 2019 May;125:e313-e318. doi: 10.1016/j.wneu.2019.01.070. Epub 2019 Jan 25.

PMID:
30685378
7.

Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.

Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, Cao Y, Ye X, Kang S, Zhao JZ.

J Neurosurg. 2015 Feb;122(2):392-9. doi: 10.3171/2014.10.JNS132369. Epub 2014 Nov 28.

PMID:
25423267
8.

The natural clinical course of hemodynamically stable adult moyamoya disease.

Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, Kang HS, Sohn CH, Oh CW.

J Neurosurg. 2015 Jan;122(1):82-9. doi: 10.3171/2014.9.JNS132281.

PMID:
25361479
9.

Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.

Giede-Jeppe A, Reichl J, Sprügel MI, Lücking H, Hoelter P, Eyüpoglu IY, Kuramatsu JB, Huttner HB, Gerner ST.

J Neurosurg. 2019 Feb 1:1-8. doi: 10.3171/2018.9.JNS181975. [Epub ahead of print]

PMID:
30717052
10.

Variation in a locus linked to platelet aggregation phenotype predicts intraparenchymal hemorrhagic volume.

Appelboom G, Piazza M, Bruce SS, Zoller SD, Hwang B, Monahan A, Hwang RY, Kisslev S, Mayer S, Meyers PM, Badjatia N, Connolly ES Jr.

Neurol Res. 2012 Apr;34(3):232-7. doi: 10.1179/1743132811Y.0000000080. Epub 2012 Mar 1.

PMID:
22449554
11.

A perfusion territory shift attributable solely to the secondary collaterals in moyamoya patients: a potential risk factor for preoperative hemorrhagic stroke revealed by t-ASL and 3D-TOF-MRA.

Gao XY, Li Q, Li JR, Zhou Q, Qu JX, Yao ZW.

J Neurosurg. 2019 Aug 9:1-9. doi: 10.3171/2019.5.JNS19803. [Epub ahead of print]

PMID:
31398708
12.

Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.

Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, Gu Y, Mao Y.

J Neurosurg. 2014 Nov;121(5):1048-55. doi: 10.3171/2014.7.JNS132434. Epub 2014 Aug 15.

PMID:
25127415
13.

Direct Bypass Surgery Vs. Combined Bypass Surgery for Hemorrhagic Moyamoya Disease: A Comparison of Angiographic Outcomes.

Zhao Y, Yu S, Lu J, Yu L, Li J, Zhang Y, Zhang D, Wang R, Zhao Y.

Front Neurol. 2018 Dec 20;9:1121. doi: 10.3389/fneur.2018.01121. eCollection 2018.

14.

Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease.

Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J.

J Neurosurg. 2018 Mar 1:1-12. doi: 10.3171/2017.10.JNS171749. [Epub ahead of print]

PMID:
29600916
15.

Moyamoya disease presenting with subarachnoid hemorrhage: Clinical features and neuroimaging of a case series.

Wan M, Han C, Xian P, Yang WZ, Li DS, Duan L.

Br J Neurosurg. 2015;29(6):804-10. doi: 10.3109/02688697.2015.1071327. Epub 2015 Aug 24.

PMID:
26313681
16.

Natural History and Risk Factor of Recurrent Hemorrhage in Hemorrhagic Adult Moyamoya Disease.

Kim KM, Kim JE, Cho WS, Kang HS, Son YJ, Han MH, Oh CW.

Neurosurgery. 2017 Aug 1;81(2):289-296. doi: 10.1093/neuros/nyw179.

PMID:
28402467
17.

Recent progress in hemorrhagic moyamoya disease.

Wan M, Duan L.

Br J Neurosurg. 2015 Apr;29(2):189-91. doi: 10.3109/02688697.2014.976177. Epub 2014 Nov 3. Review.

PMID:
25365664
18.

Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients.

Broessner G, Helbok R, Lackner P, Mitterberger M, Beer R, Engelhardt K, Brenneis C, Pfausler B, Schmutzhard E.

Crit Care Med. 2007 Sep;35(9):2025-30.

PMID:
17855816
19.

Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.

Jang DK, Huh PW, Lee KS.

J Neurosurg. 2016 Jun;124(6):1738-45. doi: 10.3171/2015.5.JNS142973. Epub 2015 Nov 13.

PMID:
26566210
20.

Heart rate variability after endovascular coiling is associated with short-term outcomes in patients with subarachnoid hemorrhage.

Cai K, Ni Y, Zhang Y, Shen L, Ji Q, Cao M.

Neurol Res. 2018 Oct;40(10):856-861. doi: 10.1080/01616412.2018.1493973. Epub 2018 Jul 26.

PMID:
30048226

Supplemental Content

Support Center